Pharmacy Staffing Survey

A recent Wall Street Journal article exposes a troubling issue: the extreme variability in pricing for generic medications. These drugs are manufactured by different companies but sold at widely differing prices. Medicare’s payments for these medications, which vary across 2,200 different price points, highlight a fragmented and inefficient market. The variability in pricing for generic medications isn’t simply a matter of poor negotiation or inefficiency. It’s a structural issue embedded in the market’s reliance on fragmented supply chains.